Wk3Assgn Case 1 17 year old non English.docx NURS 6521 Assignment 1: Case Study Assignment Walden University NURS 6521: Advanced Pharmacology Case #1 17-year-old non-English speaking female recently diagnosed with
...
Wk3Assgn Case 1 17 year old non English.docx NURS 6521 Assignment 1: Case Study Assignment Walden University NURS 6521: Advanced Pharmacology Case #1 17-year-old non-English speaking female recently diagnosed with a breast fibroadenoma. Explanation of the Health Issues/Risks Fibroadenomas are an abnormality in the growth of the breast, but they are not recognized as neoplasms. Both these benign tumors include connective tissue and the proliferation of epithelia. Although fibroadenomas do not raise the risk of breast cancer, the actual presence of cancer has rarely been reported. Unique fibroadenoma forms include giant fibroadenoma, adolescent fibroadenoma, pregnancy and lactation fibroadenoma, and multiple fibroadenoma. It is defined as a giant fibroadenoma with diameter reaching 5 cm and/or weight exceeding 500 g. Giant fibroadenoma is classified as teenage fibroadenoma in young or adolescent women. At present, the variant adolescent fibroadenoma happens to be between 11 and 18 years of age, which corresponds roughly to the beginning of adolescence, unlike fibroadenomas. Breast mass diagnosis in adolescents mostly depends on history and physical examination. The painless, solitary, and unilateral mass of juvenile fibroadenoma, without signs of infection, will double in size to 15 cm to 20 cm within three to six months. It grows easily, with prominent veins, which distorts the tissue. Youthful fibroadenoma often distresses patients cosmetically (Ng, W. K., et.al., 2011). In young patients, ultrasound may be more. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . .. .. . . . . . . . . . . . . . . . . . .. . . . .
[Show More]